Healthcare Global Enterprises Limited
NSE: HCG
Employs 6,759 permanent employees and workers, 0.3% on the year before, as filed for the year to 31 Mar 2026 on a group basis. Revenue in the quarter to 31 Dec 2024 was ₹312 cr.
Headcount
Annual, from the BRSR filed with NSE (as of 31 March each year)
| As of | Scope | Permanent | Change (%) | Contract / other | Change (%) |
|---|---|---|---|---|---|
| 31 Mar 2022 | Group | 5,679 | — | 1,093 | — |
| 31 Mar 2023 | Group | 6,131 | 452(8.0%) | 1,294 | 201(18.4%) |
| 31 Mar 2024 | Group | 6,150 | 19(0.3%) | 1,440 | 146(11.3%) |
| 31 Mar 2025 | Group | 6,736 | 586(9.5%) | 1,664 | 224(15.6%) |
| 31 Mar 2026 | Group | 6,759 | 23(0.3%) | 1,596 | −68(4.1%) |
Permanent = permanent employees + permanent workers, as defined in SEBI's BRSR. "Standalone" figures cover the listed company alone and exclude its subsidiaries.
Financials (₹ cr)
| Period | Revenue (₹ cr) | Change (%) | Employee cost (₹ cr) | Change (%) | Net profit (₹ cr) | Change (%) | Flags |
|---|---|---|---|---|---|---|---|
| Quarter ended 31 Dec 2024 | 312 | 5(1.6%) | 56 | 2(4.2%) | -37 | −53(332.9%) | |
| Quarter ended 30 Sept 2024 | 307 | 13(4.5%) | 54 | −0(0.8%) | 16 | 4(36.8%) | |
| Quarter ended 30 Jun 2024 | 294 | 13(4.7%) | 54 | 5(10.7%) | 12 | 13(765.9%) | |
| Quarter ended 31 Mar 2024 | 280 | 13(4.9%) | 49 | −1(2.3%) | -2 | −10(121.1%) | |
| Quarter ended 31 Dec 2023 | 267 | −16(5.5%) | 50 | 1(1.3%) | 8 | −5(39.2%) | |
| Quarter ended 30 Sept 2023 | 283 | 11(3.9%) | 49 | 1(1.3%) | 14 | 0(0.1%) | |
| Quarter ended 30 Jun 2023 | 272 | 14(5.2%) | 49 | 5(10.7%) | 14 | 10(227.5%) | |
| Quarter ended 31 Mar 2023 | 259 | 6(2.4%) | 44 | 1(1.9%) | 4 | −10(70.5%) | |
| Quarter ended 31 Dec 2022 | 253 | 32(14.8%) | 43 | 4(11.5%) | 14 | 32(179.0%) | |
| Quarter ended 31 Mar 2022 | 220 | 5(2.2%) | 39 | −2(4.4%) | -18 | 21(54.2%) | ⚠ |
| Quarter ended 31 Dec 2021 | 216 | −0(0.1%) | 41 | 2(5.5%) | -39 | −133(141.7%) | ⚠ |
| Quarter ended 30 Sept 2021 | 216 | 15(7.5%) | 38 | −0(0.9%) | 94 | 93(6607.1%) | ⚠ |
| Quarter ended 30 Jun 2021 | 201 | 21(11.8%) | 39 | 1(2.9%) | 1 | 155(100.9%) | ⚠ |
| Quarter ended 31 Mar 2021 | 180 | 15(9.4%) | 38 | 2(5.5%) | -153 | −140(1077.7%) | ⚠ |
| Quarter ended 31 Dec 2020 | 164 | 19(12.7%) | 36 | 2(4.9%) | -13 | −6(97.7%) | ⚠ |
| Quarter ended 30 Sept 2020 | 146 | 24(19.4%) | 34 | 5(17.4%) | -7 | 12(64.9%) | ⚠ |
| Quarter ended 30 Jun 2020 | 122 | −50(29.1%) | 29 | −7(19.3%) | -19 | 25(57.0%) | ⚠ |
| Quarter ended 31 Mar 2020 | 172 | −1(0.6%) | 36 | 0(1.2%) | -44 | −39(919.9%) | ⚠ |
| Quarter ended 31 Dec 2019 | 173 | −1(0.4%) | 36 | −0(0.4%) | -4 | −1(23.1%) | ⚠ |
| Quarter ended 30 Sept 2019 | 174 | 3(1.7%) | 36 | 0(1.3%) | -3 | −1(72.6%) | ⚠ |
| Quarter ended 30 Jun 2019 | 171 | 5(3.2%) | 35 | 1(2.5%) | -2 | −5(166.3%) | ⚠ |
| Quarter ended 31 Mar 2019 | 166 | 6(3.7%) | 34 | 1(2.5%) | 3 | 3(1783.3%) | ⚠ |
| Quarter ended 31 Dec 2018 | 160 | −2(1.2%) | 34 | 2(5.1%) | -0 | −1(116.5%) | ⚠ |
| Quarter ended 30 Sept 2018 | 162 | 8(4.9%) | 32 | 2(5.5%) | 1 | −2(67.1%) | ⚠ |
| Quarter ended 30 Jun 2018 | 154 | 2(1.1%) | 30 | 2(5.8%) | 3 | −4(56.8%) | ⚠ |
| Quarter ended 31 Mar 2018 | 153 | — | 29 | — | 8 | — | ⚠ |